Clarivate (CLVT) AI Stock Analysis

• Market Cap: $2.90B
• Dividend Yield: N/A
• Average Volume (3M): 4.42M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.97
• Revenue Growth: -3.92%
• EPS Growth: 67.52%
• Country: US
• Employees: 12,000
• Sector: Technology
• Sector Strength: 94
• Industry: Information Technology Services
• EPS (TTM): 0.18
• Shares Outstanding: 672,219,060
• 10 Day Avg. Volume: 5,069,218
• 30 Day Avg. Volume: 4,423,322
• PEG Ratio: 0.16
• Price to Book (P/B): 0.69
• Price to Sales (P/S): 1.38
• P/FCF Ratio: 9.86
• Enterprise Value/Market Cap: 2.47
• Enterprise Value/Revenue: 2.86
• Enterprise Value/Gross Profit: 4.33
• Enterprise Value/Ebitda: 10.44
• 1Y Price Target: $5.00
• Price Target Upside: 16.01% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 6

• Rating: 56 Neutral
• Price Target: $4.50 ▲(4.41% Upside)

Clarivate's overall stock score reflects significant financial challenges, particularly in profitability and valuation. While technical analysis and earnings call insights show some positive trends, the company's high leverage and declining equity remain concerns. Strategic initiatives and corporate events provide some optimism for future growth.

Positive Factors

Financial Guidance

Management is optimistic, indicating the possibility of reaching the upper half of previously issued ranges on recurring revenue growth, revenue, and adjusted EBITDA.

Financial Performance

Clarivate's second-quarter revenue exceeded estimates and consensus, with strong performance in academia, government, life sciences, healthcare, and IP sectors.

Negative Factors

Government and Education Funding

A&G end-markets are experiencing pressure from reduced U.S. federal government spending and tighter constraints on higher education and research funding.

Market Reaction

Shares traded lower due to the lack of a substantial update on the firm's strategic review.

Clarivate Business Overview & Revenue Model

Company Description

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

How the Company Makes Money

Clarivate generates revenue through a combination of subscription-based services, software licenses, and transactional services. Its key revenue streams include subscription fees for access to its databases and analytical tools, which are utilized by researchers and institutions. The company also earns revenue from licensing its proprietary datasets and providing consulting services to help clients optimize their research and intellectual property strategies. Significant partnerships with universities, research institutions, and corporations enhance its reach and credibility in the market, contributing to a steady flow of income. Additionally, Clarivate's investment in expanding its product offerings and entering new markets plays a crucial role in driving growth and profitability.

Clarivate Financial Statement Overview

Summary

Clarivate is facing significant challenges in its financial health, particularly in profitability and revenue growth. Despite a strong cash flow position, the company needs to address operational inefficiencies and stabilize its revenue base. High leverage and declining equity highlight potential risks, necessitating strategic financial management to improve overall financial stability.

Income Statement

Clarivate's income statement highlights significant challenges. The TTM (Trailing-Twelve-Months) revenue has decreased compared to the previous year, indicating revenue contraction. The gross profit margin remains healthy, but negative EBIT and net income margins suggest operational inefficiencies and profitability issues. Although EBITDA is positive, it is insufficient to cover operating losses, indicating potential financial instability.

Balance Sheet

The balance sheet reflects a moderate level of financial stability. The company has a manageable debt-to-equity ratio, but the significant total liabilities suggest a high leverage position. The equity ratio is reasonable, though the declining stockholders' equity may pose risks. Overall, the balance sheet shows moderate stability with potential risks from high leverage.

Cash Flow

Cash flow analysis reveals a moderately positive outlook. Operating cash flow remains robust, and free cash flow is positive, indicating good cash generation capability. However, the free cash flow growth rate is negative, suggesting potential challenges in maintaining cash flow levels. The operating cash flow to net income ratio is favorable, indicating efficient cash conversion despite profitability issues.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.50B	2.56B	2.63B	2.66B	1.88B	1.88B
Gross Profit	1.65B	1.69B	1.72B	1.71B	1.25B	1.25B
EBITDA	685.00M	456.60M	-10.50M	-3.01B	532.15M	52.38M
Net Income	-433.30M	-636.70M	-911.20M	-3.96B	-270.50M	-270.45M
Balance Sheet
Total Assets	11.42B	11.49B	12.71B	13.94B	13.94B	20.18B
Cash, Cash Equivalents and Short-Term Investments	362.60M	295.20M	370.70M	348.80M	348.80M	430.88M
Total Debt	4.59B	4.59B	4.81B	5.10B	5.10B	5.61B
Total Liabilities	6.43B	6.35B	6.71B	7.13B	7.13B	8.26B
Stockholders Equity	4.99B	5.14B	5.99B	6.81B	6.81B	11.93B
Cash Flow
Free Cash Flow	346.00M	357.50M	501.70M	306.40M	205.30M	205.22M
Operating Cash Flow	631.70M	646.60M	744.20M	509.30M	323.80M	323.77M
Investing Cash Flow	-197.00M	-236.70M	-237.40M	57.30M	-4.04B	-4.04B
Financing Cash Flow	-459.80M	-470.10M	-496.50M	-759.20M	4.03B	4.03B

Clarivate Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4.31
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLVT, the sentiment is Positive. The current price of 4.31 is above the 20-day moving average (MA) of 4.08, above the 50-day MA of 4.22, and below the 200-day MA of 4.57, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 58.38 is Neutral, neither overbought nor oversold. The STOCH value of 88.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CLVT.

Clarivate Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WNS	79 Outperform	$3.21B	20.01	21.23%	―	1.94%	26.15%
PAY	76 Outperform	$4.67B	85.41	11.59%	―	49.35%	72.05%
ASGN	69 Neutral	$2.22B	16.09	7.71%	―	-6.31%	-23.56%
DXC	68 Neutral	$2.47B	6.68	12.60%	―	-4.93%	497.03%
Sector *	61 Neutral	$36.30B	7.26	-7.27%	1.97%	7.74%	-7.92%
AI	60 Neutral	$2.41B	―	-33.73%	―	25.27%	4.68%
CLVT	56 Neutral	$2.90B	―	-8.18%	―	-3.92%	67.52%

Clarivate Corporate Events

Clarivate Increases Revolving Credit by $75 Million

On August 5, 2025, Clarivate Plc’s subsidiaries amended their existing Credit Agreement, originally dated October 31, 2019, to increase the total revolving credit commitments by $75 million, bringing the total to $775 million. This amendment, which maintains the same terms as the existing agreement, is expected to enhance Clarivate’s financial flexibility and support its operational and strategic initiatives.

The most recent analyst rating on (CLVT) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Announces Leadership Change in IP Segment

Clarivate Plc announced significant leadership changes within its Intellectual Property segment, with Gordon Samson set to depart from his role as President, effective September 7, 2025, and remain in a non-executive role until the end of the year. In a strategic move to drive long-term growth, Maroun S. Mourad will assume the role of President, Intellectual Property, effective September 8, 2025. Mourad brings extensive experience in data analytics and technology-enabled services, having previously led the Claims Solutions division at Verisk Analytics. The transition is part of Clarivate’s commitment to accelerating innovation and growth within its IP business, and Mourad’s appointment is expected to enhance the company’s focus on delivering quality results and customer-centric solutions.

The most recent analyst rating on (CLVT) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Reports Q2 2025 Results with Revenue Decline

On July 30, 2025, Clarivate reported its second-quarter results, highlighting a decrease in total revenues to $621.4 million from $650.3 million in the same period of 2024, attributed to inorganic divestitures and disposals. Despite this, the company saw a 0.5% increase in organic revenues, driven by a rise in organic recurring revenues. Clarivate also repurchased 11.5 million ordinary shares and reaffirmed its 2025 outlook. The net loss for the quarter was significantly reduced to $72.0 million from $304.3 million in 2024, indicating improved financial performance. The company is optimistic about future profitability, supported by enhancements in its sales operating model and AI advancements in its IP business.

The most recent analyst rating on (CLVT) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Elects Kenneth Cornick to Board of Directors

On July 22, 2025, Clarivate Plc announced the election of Kenneth Cornick to its Board of Directors, increasing the board size from 10 to 11 members. Cornick, who co-founded Clear Secure, Inc. and has extensive experience in financial and board roles, will join the Audit Committee, potentially strengthening Clarivate’s governance and strategic oversight.

The most recent analyst rating on (CLVT) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Secures $500M Term Loans in May 2025

On May 30, 2025, Clarivate Plc’s subsidiaries, including Camelot Finance S.A., amended their existing credit agreement to secure a new $500 million tranche of incremental term loans maturing in 2031. These loans were used to redeem $500 million of outstanding senior secured notes due in 2026, leaving $200 million still outstanding. This strategic financial move allows Clarivate to extend the majority of its 2026 debt maturity, taking advantage of improved credit market conditions and maintaining flexibility in capital allocation.

The most recent analyst rating on (CLVT) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Announces Partial Redemption of Senior Notes

On May 19, 2025, Camelot Finance S.A., a subsidiary of Clarivate Plc, announced a conditional partial redemption of $500 million of its 4.50% Senior Secured Notes due 2026. This redemption is contingent upon successful debt financing transactions to fund the redemption price, leaving $200 million of the notes outstanding after completion.

The most recent analyst rating on (CLVT) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.